InsidersTradesSigma
Track the 羚锐制药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 羚锐制药 has logged 5 reports. Market capitalisation: €13.1bn. The latest transaction was disclosed on 24 May 2024 (Sale). Among the most active insiders: 吴希振. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
羚锐制药是一家在XSHG市场上市的健康和制药公司。它专注于药品的研发和制造。